期刊
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
卷 11, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fcimb.2021.769950
关键词
vagina; neovagina; transgender; gender diverse; microbiome; bacterial vaginosis
资金
- Canada Research Chair (Canadian Institutes of Health Research) [950-233211]
- Schulich School of Medicine and Dentistry, Western University
- National Institute for Allergy and Infectious Diseases of the National Institutes of Health [R01NR015495, R01AI123002]
- Canadian Institutes of Health Research Sex and Gender Science Chair [GSB-171372]
This review summarizes the impact of gender-affirming medical care on the vagina of transmasculine individuals and the neovagina of transfeminine individuals, including hormone therapy and surgery. The study focuses on the epithelium and local microbiota of the vagina and neovagina, as well as key determinants and knowledge gaps in gynecological health.
Transgender and gender diverse individuals may seek gender-affirming medical care, such as hormone therapy or surgery, to produce primary and/or secondary sex characteristics that are more congruent with their gender. Gender-affirming medical care for transmasculine individuals can include testosterone therapy, which suppresses circulating estrogen and can lead to changes in the vaginal epithelium that are reminiscent of the post-menopausal period in cisgender females. Among transfeminine individuals, gender-affirming medical care can include vaginoplasty, which is the surgical creation of a vulva and neovaginal canal, commonly using penile and scrotal skin. The effect of gender-affirming medical care on the vagina of transmasculine individuals and on the neovagina of transfeminine individuals is poorly characterized. This review summarizes what is known of the epithelium and local microbiota of the testosterone-exposed vagina and the neovagina. We focus on potential pathogens and determinants of gynecological health and identify key knowledge gaps for future research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据